For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
News Release
House-passed SAFE Banking Act Would End Federal Threat to Banks Dealing with Legal Cannabis Businesses
The House has passed a bill allowing banks to do business with cannabis companies, the SAFE Banking Act. While Senate action on the…
The Washington Examiner
Racially Charged Atmosphere Could Spell End Of Menthol Cigarettes
The Washington Examiner cites Senior Fellow Michelle Minton on menthol cigarettes: Michelle Minton, a senior fellow at the libertarian Competitive Enterprise…
National Review
The CDC Shouldn’t Treat Racism as a Public-Health Crisis
The Centers for Disease Control and Prevention was founded in 1946 as the Communicable Disease Center, with a simple goal: prevent the spread of…
Orlando Sentinel
Desantis’ Ban Of Vaccine Passports Could Lead To Showdown With Businesses In Florida
The Orlando Sentinel cites Senior Fellow Joel Zinberg on vaccine passports: “Every business has economic and reputational incentives to ensure that…
The New York Post
Agencies are Being Cautious with J&J Vaccine — and it Could Cost Lives: Doctor
The Food and Drug Administration and the Centers for Disease Control and Prevention announced Tuesday that they are recommending a pause in the use of…
The Center Square
Study: Vaccine Passports May Soon be Obsolete
The Center Square cites CEI’s report by Senior Fellow Joel Zinberg on vaccine passports: The Competitive Enterprise Institute released a new …